Generic drug from Gaviscon
Therapeutic class: Gastro-Entero-Hepatology
Active ingredients: Sodium alginate + Sodium bicarbonate
laboratory: Sanofi-Aventis France
in sachet box of 24 sachets of 10 ml
All forms
Indication
Symptomatic treatment of gastroesophageal reflux.
Dosage SODIUM ALGINATE / SODIUM BICARBONATE ZENTIVA 500 mg / 267 mg oral suspension in sachets box of 24 sachets of 10 ml
Symptomatic treatment of gastroesophageal reflux.
Against indications
Hypersensitivity to the active substances or to any of the excipients.
Side effects Alginate / bicarb Sodium Zentiva
Related to calcium carbonate:
· Possible constipation, which is exceptional thanks to the presence of alginate.
· In prolonged use, possible hypercalcemia with risk of nephrolithiasis and renal failure.
Allergic manifestations such as urticaria, bronchospasm, anaphylactic or anaphylactoid reactions have been reported.
Reporting of suspected adverse reactions
The reporting of suspected adverse reactions after authorization of the drug is important. It allows continuous monitoring of the benefit / risk ratio of the drug. Health professionals declare any suspected adverse reaction via the national reporting system: National Agency for the Safety of Medicines and Health Products (ANSM) and the network of Regional Pharmacovigilance Centers - Website: www.ansm.sante.fr.